THE USE OF LOW-DOSE BROMOCRIPTINE TO TREAT END OF DOSE FAILURE IN LEVODOPA TREATED PARKINSONS-DISEASE PATIENTS - THE RESULTS OF A MULTICENTER STUDY

被引：0

|

作者：

GRIMES, JD

KING, DB

KOFMAN, OS

MOLINANEGRO, P

WILSON, AF

BOUCHARD, S

机构：

来源：

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 1983年 / 10卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：132 / 132

页数：1

相关论文

共 50 条

[21] A DOSE-FINDING CLINICAL AND PHARMACOKINETIC STUDY OF ENTACAPONE AS AN ADJUVANT TO LEVODOPA TREATMENT IN PARKINSONS-DISEASE
RUOTTINEN, H
RINNE, UK
AHTILA, S
GORDIN, A
NEUROLOGY, 1994, 44 (04) : A258 - A259
[22] RESULTS OF A MULTICENTER STUDY WITH 1581 PATIENTS SUFFERING FROM PARKINSONS-DISEASE
SCHULTE, RM
MEDIZINISCHE WELT, 1985, 36 (48): : 1553 - 1559
[23] EARLY COMBINATION OF SELEGILINE AND LOW-DOSE LEVODOPA AS INITIAL SYMPTOMATIC THERAPY IN PARKINSONS-DISEASE - EXPERIENCE IN 26 PATIENTS RECEIVING COMBINED THERAPY FOR 26 MONTHS
ELIZAN, TS
MOROS, DA
YAHR, MD
ARCHIVES OF NEUROLOGY, 1991, 48 (01) : 31 - 34
[24] Low-dose levodopa therapy in Japanese patients with Parkinson's disease: A retrospective study
Kitagawa, M
Tashiro, K
INTERNAL MEDICINE, 2005, 44 (09) : 939 - 943
[25] TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT IN PATIENTS WITH PARKINSONS-DISEASE (PD) EXPERIENCING END-OF-DOSE MOTOR FLUCTUATIONS
KURTH, MC
ADLER, CH
STHILAIRE, M
SINGER, C
WATERS, C
CHERNIK, DA
DORFLINGER, E
YOO, K
DAVIS, T
HOEHN, M
LEWITT, P
MONTGOMERY, E
MUENTER, M
TANNER, C
TRUGMAN, J
NEUROLOGY, 1995, 45 (04) : A275 - A276
[26] L-DEPRENYL AS AN ADJUNCT TO LOW-DOSE BROMOCRIPTINE IN EARLY PARKINSONS-DISEASE - A SHORT-TERM, DOUBLE-BLIND, AND PROSPECTIVE FOLLOW-UP-STUDY
CALZETTI, S
NEGROTTI, A
CASSIO, A
CLINICAL NEUROPHARMACOLOGY, 1995, 18 (03) : 250 - 257
[27] COMPARISON OF BROMOCRIPTINE AND LEVODOPA AS 1ST LINE TREATMENT OF PARKINSONS-DISEASE - RESULTS OF A 3 YEAR PROSPECTIVE RANDOMIZED STUDY
MONTASTRUC, JL
RASCOL, O
RASCOL, A
REVUE NEUROLOGIQUE, 1990, 146 (02) : 144 - 147
[28] LOW-DOSE L-DOPA THERAPY IN PARKINSONS-DISEASE - A 6-YEAR FOLLOW-UP-STUDY
POEWE, WH
LEES, AJ
STERN, GM
NEUROLOGY, 1986, 36 (11) : 1528 - 1530
[29] MOOD CHANGES ASSOCIATED WITH END-OF-DOSE DETERIORATION IN PARKINSONS-DISEASE - A CONTROLLED-STUDY
CANTELLO, R
GILLI, M
RICCIO, A
BERGAMASCO, B
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (10): : 1182 - 1190
[30] SUPPRESSION OF DYSKINESIAS IN ADVANCED PARKINSONS-DISEASE .1. CONTINUOUS INTRAVENOUS LEVODOPA SHIFTS DOSE-RESPONSE FOR PRODUCTION OF DYSKINESIAS BUT NOT FOR RELIEF OF PARKINSONISM IN PATIENTS WITH ADVANCED PARKINSONS-DISEASE
SCHUH, LA
BENNETT, JP
NEUROLOGY, 1993, 43 (08) : 1545 - 1550

← 1 2 3 4 5 →